Takeda Pharmaceutical Co., Ltd. (TAK)
18.66
+0.12
(+0.65%)
USD |
NYSE |
Feb 19, 16:00
18.68
+0.02
(+0.11%)
Pre-Market: 20:00
Takeda Pharmaceutical Market Cap : 58.93B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.472B |
| Protagonist Therapeutics, Inc. | 5.194B |
| Nxera Pharma Co., Ltd. | 492.29M |
| PeptiDream Inc. | 1.198B |
| Stemcell Holdings, Inc. | 60.00M |
Market Cap Related Metrics
| PE Ratio | 77.49 |
| PS Ratio | 1.984 |
| Price to Book Value | 1.209 |
| Price to Free Cash Flow | 13.61 |
| Price | 18.66 |
| Earnings Yield | 1.29% |
| Operating PE Ratio | 16.83 |
| Normalized PE Ratio | 53.54 |